Ascendis Pharma Investigational Site

Seville 41014

0 studies enrolling now · 3 studies all time

What they study most

2L+ Cervical Cancer, Adult Growth Hormone Deficiency, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, Hormone Deficiency, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Post Anti-PD-(L)1 Non-Small Cell Lung Cancer

Studies at this site

• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency — Completed
• A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency — Completed
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling